Skip to content

A Clinical Study of Ultrasound-Guided Acupotomy Combined with Mindfulness Meditation to Improve Lumbar Myofascial Pain Syndrome

A Clinical Study of Ultrasound-Guided Acupotomy Combined with Mindfulness Meditation to Improve Lumbar Myofascial Pain Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001549
Enrollment
Unknown
Registered
2025-08-09
Start date
2025-08-22
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lumbar Myofascial Pain Syndrome

Interventions

Experimental Group:Ultrasound-guided needle knife combined with mindfulness meditation
Control Group 2:Take celecoxib orally
Control Group 1:Ultrasound-guided needle knife

Sponsors

Fujian University of Traditional Chinese Medicine Affiliated People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Meet the MPS diagnostic criteria; (2) VAS score >5; (3) The chief complaint is low back pain that has lasted for more than 3 months; (4) Be between 18 and 60 years old; (5) Has never received small needle knife acupuncture meditation treatment and has not taken anti-inflammatory analgesic or hormone drugs; (6) The patient voluntarily participates and signs the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Contraindications for celecoxib: including those allergic to celecoxib sulfonamides or NSAIDs patients with active peptic ulcers/bleeding patients undergoing coronary artery bypass grafting perioperative patients those with severe heart failure and those with severe liver dysfunction; (2) Needle-knife treatment cannot be performed; (3) There are severe coagulation disorders; (4) Ankylosing spondylitis lumbar spine fractures dislocations intervertebral disc protrusions; (5) Abnormal lumbosacral nerve function; (6) During pregnancy or lactation; (7) Cognitive dysfunction; (8) There is local skin rupture or erythema; (9) Rheumatic diseases; (10) Combined with serious organ diseases such as heart cerebrovascular liver and kidney diseases or mental disorders; (11) Received mindfulness meditation therapy.

Design outcomes

Primary

MeasureTime frame
SF-MPQ;

Secondary

MeasureTime frame
PSQI;Hospital Anxiety and Depression Scale HADS;Lumbar spine range of motion;

Countries

China

Contacts

Public ContactZhang Wenbing

Fujian University of Traditional Chinese Medicine Affiliated People's Hospital

zwb201919@126.com13338282136

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026